These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
915 related articles for article (PubMed ID: 18515739)
21. [Surgical management of hereditary medullary carcinoma of the thyroid in patients with "RET" proto-oncogene mutation]. Calbo L; Spinelli C; Lazzara S; Melita P; Miccoli P Chir Ital; 1998; 50(5-6):47-51. PubMed ID: 10392193 [TBL] [Abstract][Full Text] [Related]
22. [Decision making in postoperative incidentally found small C-cell-carcinoma]. Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440 [TBL] [Abstract][Full Text] [Related]
23. New directions in the treatment of thyroid cancer. You YN; Lakhani V; Wells SA J Am Coll Surg; 2007 Oct; 205(4 Suppl):S45-8. PubMed ID: 17916518 [No Abstract] [Full Text] [Related]
24. [Medullary carcinoma of the thyroid]. Obara T Nihon Rinsho; 2006 May; Suppl 1():478-81. PubMed ID: 16776194 [No Abstract] [Full Text] [Related]
25. Invited commentary: medullary thyroid cancer: the importance of RET testing. Evans DB; Shapiro SE; Cote GJ Surgery; 2007 Jan; 141(1):96-9. PubMed ID: 17188173 [No Abstract] [Full Text] [Related]
26. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2. Moore SW; Appfelstaedt J; Zaahl MG J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543 [TBL] [Abstract][Full Text] [Related]
28. Surgical treatment of medullary carcinoma of the thyroid. Block MA Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281 [TBL] [Abstract][Full Text] [Related]
30. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report. Menon MM; Simha MR Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654 [TBL] [Abstract][Full Text] [Related]
31. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels. Machens A; Lorenz K; Dralle H Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924 [TBL] [Abstract][Full Text] [Related]
32. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617 [TBL] [Abstract][Full Text] [Related]
37. Indication and timing of thyroid surgery for patients with hereditary medullary thyroid cancer syndromes. Ogilvie JB; Kebebew E J Natl Compr Canc Netw; 2006 Feb; 4(2):139-47. PubMed ID: 16451770 [TBL] [Abstract][Full Text] [Related]
38. Thyroid cancer genetics: multiple endocrine neoplasia type 2, non-medullary familial thyroid cancer, and familial syndromes associated with thyroid cancer. Richards ML Surg Oncol Clin N Am; 2009 Jan; 18(1):39-52, viii. PubMed ID: 19056041 [TBL] [Abstract][Full Text] [Related]
39. Current management of medullary thyroid cancer. Milan SA; Sosa JA; Roman SA Minerva Chir; 2010 Feb; 65(1):27-37. PubMed ID: 20212415 [TBL] [Abstract][Full Text] [Related]